Relenza - An Australian success story Updated 18/06/2025     Return to unit

This page shows the influenza enzyme neuraminidase being blocked with the antiviral drug zanamivir (Relenza). Zanamivir was developed in Australia and has had a significant impact on treating infleunza worldwide.

Click and hold the mouse button within the JSmol window to rotate. (This may take some time to load)

Alternate views